A Systems Quarter Dressed as an Odyssey Quarter: Revenue $102.8M (+12%) and Adjusted EPS $0.43 (+65%) Beat Consensus by 9% and 54%, But Technology Products and Services Supplied the Entire Beat While Q2 Box Office Rose Just 1%; The Odyssey Took 20% of Global Opening Weekend on Under 1% of Screens and Contributed Nothing to the Quarter; Guidance Reiterated, Not Raised, Leaving 61% of the $1.4B Target in the Back Half

Coverage Continuity: Grading Our Own Q1 Tripwires

Our Q1 2026 note maintained Outperform with the stock near $33 and a $40-$52 fair value range, on the argument that an optically soft first quarter was a known China comparison rather than a structural problem. That note set explicit, numeric conditions for changing the rating. Those conditions produced a genuinely split verdict this quarter, and it is worth being direct about it before anything else.

The box-office tripwire was tripped. We are not going to pretend otherwise, and a note that quietly drops its own stated conditions when they become inconvenient is worth nothing. What matters is whether the reason we set that tripwire held. We set $325M because a Q2 below it would suggest the Q1 weakness was structural rather than a China comparison. It was not structural. International excluding Mainland China grew 24% in the quarter, the network expanded 9% in rest of world, the best Q2 box office since 2019 was delivered, and the P&L beat consensus by 9% on revenue and 54% on adjusted EPS with the softer box office. The mechanism of the shortfall is the same one we identified in Q1, and it is still Greater China. The test failed on the number and passed on the diagnosis.

The second correction we owe ourselves is about what the $325M tripwire assumed. It implicitly assumed box office and revenue move together. This quarter broke that link: box office rose 1% while revenue rose 12% and adjusted EBITDA rose 23%. The systems business, the lease-incentive take rates, and the sales-arrangement mix now do enough work that a flat box-office quarter can still be a strong earnings quarter. Any tripwire we set going forward should be denominated in earnings and margin, not box office alone. That is a real lesson from this print, and it changes how we frame the conditions at the end of this note.

The last continuity item concerns tone. Q1's call was led by the CFO with the CEO recovering from pneumonia and only gradually resuming oversight. The CEO led this call in full, and the shift is unmistakable in the register: from a careful defence of a soft quarter to an unusually unguarded account of a good one, including a closing admission that the company's own high expectations were exceeded.

Results vs. Consensus

Q2 2026 Scorecard

Consensus for revenue spanned $93.75M to $94.37M across providers and for adjusted EPS spanned $0.27 to $0.30. The table uses the most widely cited set. No adjusted EBITDA consensus could be verified across two independent providers, so none is quoted; the $48.0M print is assessed against the prior-year figure and the company's own full-year margin guidance instead. The GAAP diluted figure of $0.27 is shown for completeness and is not the basis on which the consensus was struck.

Year-over-Year Comparison

Sequential Comparison

Q1 2026 figures for revenue, gross margin, adjusted EBITDA and adjusted EPS are derived by subtracting the reported second quarter from the reported six-month totals in the same filing, and reconcile to the first-quarter release. Q1 global box office and installations are as separately reported for that quarter.

Revenue

Revenue of $102.8M grew 12% on box office that grew 1%. That gap is the whole story of the quarter. Technology sales more than any other line drove it, rising to $26.7M from $18.8M, reflecting 18 systems installed under sales arrangements against 13 a year ago. Image enhancement and maintenance services, the line most directly geared to box office, grew only to $53.2M from $50.9M. Technology rentals reached $20.0M from $19.1M. The revenue mix moved toward the up-front, higher-margin, box-office-independent part of the model, and that shift is what allowed a flat exhibition quarter to produce a double-digit revenue print. It also means the revenue growth rate is not a clean read on underlying demand for the IMAX experience this quarter; the demand signal is the 1%, and the 12% is the model's diversification working as designed.

Margins

Gross margin of 61.2% expanded 270 basis points, and adjusted EBITDA margin of 46.6% expanded 400. Both are mix stories with a genuine leverage component underneath. The mix piece is the shift toward system sales and renewals, which carry higher margin than box-office-linked services. The leverage piece is real and was quantified on the call: the incrementality in the model begins to compound above roughly $250M of quarterly box office, and $285M cleared that threshold. Below the gross-margin line, cost discipline did the rest, with operating expenses excluding stock compensation falling to $29M from $30M. Two items ran the wrong way and are worth flagging because they are excluded from the adjusted figures: restructuring and other impairments of $2.3M against $0.8M, and a credit loss expense of $1.5M against a small reversal a year ago. Neither is large, but a credit loss swing in a business that finances exhibitor receivables deserves to be watched rather than adjusted away.

Earnings

Adjusted EPS of $0.43 against $0.26 is a 65% increase, and it outran both adjusted EBITDA growth of 23% and GAAP diluted EPS growth of 35%. Those gaps are worth decomposing, because the usual assumption is that a flattering adjusted number is hiding something, and here the opposite is true. The prior-year quarter contained a $3.8M employee retention credit, a genuine one-time benefit that inflated Q2 2025 GAAP earnings. The company correctly removed it in arriving at prior-year adjusted net income of $14.6M. The consequence is that the adjusted comparison of $24.2M against $14.6M is the clean like-for-like, while the GAAP comparison is the one distorted, with the prior-year base flattered and this year's 35% GAAP growth correspondingly understated. A smaller deduction for non-controlling interests ($0.5M against $1.0M) contributes about three points of the adjusted growth.

The tax line is the strongest evidence that the progress is operational. Income before taxes rose 45% while net income rose 30%, because income tax expense nearly tripled to $3.5M from $1.2M and the effective rate went from roughly 9% to roughly 18%. Earnings grew this much despite a doubling of the tax burden and a 3% higher diluted share count, not because of any help below the operating line.

Segment Performance

Content Solutions

Revenue of $34.7M grew 2% and gross margin of $21.9M fell 2%, taking segment margin from 66.0% to 63.2%. This is the segment that captures IMAX's share of the box office, and it is the one that missed. Growth came from international markets outside China, headlined by Michael at $69M in IMAX box office, with The Mandalorian & Grogu at $42M and The Super Mario Galaxy Movie at $39M rounding out the top three titles. The absence in that list is any Greater China contribution of consequence, and the segment's margin compression follows directly from the geographic mix: China carries high-margin remastering economics, and when the China slate underdelivers, the mix damage shows up in this line first.

"In our Content Solutions segment, revenues grew 2% to $35 million, driven by growth in international markets, excluding China, headlined by the breakout title, Michael."
— Natasha Fernandes, Chief Financial Officer

The forward-looking part of the segment commentary is more interesting than the quarter. The CFO characterised the second-half slate as exceptional and, in the same breath, disclosed that The Odyssey's IMAX box office was already north of $80M less than a week after release. That figure belongs to the third quarter and is the reason this segment's next print will look nothing like this one.

One piece of context materially softens the margin comparison. The 66.0% prior-year segment margin was not a normal base: Q2 2025 Content Solutions gross margin grew 39% year over year on box office that grew 41%, a quarter the company itself described as delivering significant segment margin expansion. Measuring this quarter against that one sets a demanding bar, and 63.2% on a far weaker box-office backdrop is a less troubling outcome than the raw delta suggests.

Assessment: Two consecutive quarters of year-over-year gross margin compression in the segment that is supposed to embody the premium-pricing thesis still warrants tracking, and it is currently masked by the systems business. But the compression is explicable through China mix and a demanding prior-year comp rather than through any erosion in IMAX's share of the gate, and the third quarter will almost certainly reverse it violently. But the reversal will be a single-title reversal, and we would rather see this line's margin recover on breadth than on Nolan. Watch whether Q3 segment margin returns above 66% and, more importantly, whether it holds there in Q4 once Dune: Part Three is doing the same job.

Technology Products and Services

Revenue of $64.8M grew 16% and gross margin of $39.0M grew 29%, lifting segment margin from 54.2% to 60.2%. This segment beat consensus revenue by 13% and consensus gross margin by 24%, and it is the reason the quarter looked the way it did. Three drivers were identified, and they are worth separating because they have very different durability. First, box office above the $250M quarterly threshold triggers the incrementality in the rental economics. Second, the lease incentives IMAX has been paying to exhibitors are being recouped through higher take rates, which is a deliberate capital-for-margin trade the company began flagging last quarter. Third, rising box-office projections feed directly into the average selling price of a system, because the value of an IMAX screen to an exhibitor is a function of what it is expected to gross.

"Another part of that is we have talked about, particularly in last quarter's call about our contribution of lease incentives to exhibitors and that we would be taking an additional take rate from them. And so you're seeing part of that flow through as well on the Tech Products and Services margin, which we believe will continue as we continue to invest in helping the rollout of systems worldwide."
— Natasha Fernandes, Chief Financial Officer

The third driver is the most strategically significant and the least discussed. It creates a reflexive loop in which better box office raises system prices, which raises segment margin, independent of the box office IMAX itself collects in the period. The Odyssey's performance therefore improves the pricing of systems sold in the third and fourth quarters, and that benefit accrues whether or not any given exhibitor's screens play the film.

Assessment: The margin expansion here is structural rather than a one-quarter mix accident, and it is the most underappreciated element of the print. The lease-incentive-for-take-rate trade converts balance sheet into recurring margin and the company has explicitly said it expects the effect to continue. The caution is that the first driver, box-office incrementality, cuts both ways: a quarter below $250M reverses it. With first-half box office at $545M against a $1.4B target, the back half should clear the threshold in both quarters comfortably.

All Other

Revenue of $3.3M grew 61% and gross margin of $2.0M doubled, against consensus of $2.2M and $1.0M respectively. The segment houses the streaming and consumer technology businesses plus ancillary activity, and it is small enough that percentage moves overstate its importance. It is worth watching for one reason: it is where the merchandising economics and the newly announced in-vehicle entertainment partnership would land if either scales. Neither is material today.

Assessment: Immaterial to this quarter and possibly not immaterial in two years. The popcorn-bucket sell-through described on the call, with the first drop gone in under two hours and the China drop in 63 seconds, is a genuine consumer-demand signal on a product line that carries no content cost. Management conceded it under-produced. That is an unforced error but a cheap one to fix.

Network, Installations and Backlog

Two of these lines need care. Year-to-date signings of 59 against 123 looks alarming until the prior-year figure is decomposed: 2025 included a single 70-system traditional joint revenue sharing agreement with AMC. Excluding it, the comparison is 59 against 53, which is growth. Management put the year-to-date count at 62 as of the call date, three weeks after quarter-end. Notable individual deals in the quarter were the 10-system HOYTS agreement across Australia and New Zealand, a 5-system Georgia Theatre deal in the United States, and 3-system deals in each of India, Turkey and Vietnam.

The backlog decline is the line that does not decompose away. Total backlog of 421 is down 80 systems, and the filing discloses that Greater China backlog changes include the cancellation of 17 system locations that IMAX and its exhibition customers mutually deemed no longer beneficial. Set against that, the composition improved sharply: sales arrangements rose to 234 from 165, and those carry recognised revenue and margin up front rather than a share of a future gate.

Assessment: Installations and signings are healthy and the mix is moving the right way on both. Backlog is the one forward indicator that deteriorated, and the deterioration is concentrated in China and in the joint revenue sharing categories the company has deliberately been rationing. We read this as management choosing quality over quantity in a market it is de-emphasising rather than as demand failure, which the 80% new-location signings rate supports. But a second consecutive quarter of backlog decline would change that reading, and the disclosure that 17 China locations were cancelled by mutual agreement is a reminder that the Chinese exhibition market remains the softest part of the network.

The Odyssey: The Quarter That Is Not In This Quarter

The single most consequential set of disclosures on this call describes events that occurred entirely after the reporting period. Christopher Nolan's The Odyssey, the first feature-length release shot entirely with IMAX film cameras, opened in the third quarter. None of what follows is in the Q2 numbers, and all of it is in the stock.

The 20% share on under 1% of screens is the number that matters for the thesis, because it is a statement about pricing power and scarcity rather than about one film. It says that when a filmmaker builds for the format, the format captures a fifth of the world's demand for that film from a rounding error of the world's screens. That is the premium-tier argument, demonstrated rather than asserted.

The second-order economics are better than the headline. Management disclosed that IMAX takes a materially larger share of the gate in film houses than in digital ones, because it subsidises print costs and participates in the print economics. So the 41 film locations generating $153,000 per screen convert to IMAX revenue at a higher rate than an equivalent dollar of digital box office. Those locations will also play the film for months rather than weeks, with sellouts already recorded into the seventh and eighth week of the run.

"IMAX delivered $52 million in its global opening, the biggest global opening weekend in our history on a like-for-like basis, given the film is yet to open in China, Japan and South Korea. That amounted to a staggering 20% share of the film's worldwide debut on less than 1% of total screens."
— Richard L. Gelfond, Chief Executive Officer

Assessment: This is the confirmation the thesis needed, and it arrived larger than we modelled. Our Q1 note set 17% global indexing as the threshold that would push the full-year box office toward the upper end of our range; the film delivered 20% with three major Asian markets still closed. The correct inference is not that IMAX will earn Odyssey-like economics routinely, because it will not. It is that the ceiling on what a purpose-built IMAX title can do has moved up materially, that the ceiling is now known to studios and filmmakers, and that the pipeline of directors wanting to shoot on the format should widen as a result. Management said at least four IMAX 70mm titles are already set for 2027.

Key Topics & Management Commentary

Overall Management Tone: Unusually unguarded, and materially more confident than the prior quarter. Management ran the call as a demonstration rather than a defence, volunteering granular and occasionally unflattering detail (the merchandise under-production, the disappointing Chinese first half) rather than steering around it. The one place the posture and the disclosure did not align was guidance: the same call that described results exceeding the company's own high expectations left every full-year number unchanged, and no explanation for that gap was offered or requested.

1. Guidance Reiterated Against a Print That Argues for a Raise

Every FY26 metric was left intact: $1.4B of global box office, 160 to 175 installations, mid-40s adjusted EBITDA margin. The CFO stated the position explicitly, and the CEO separately said he was near-certain the film would beat its budget. Reconciling those two statements is the central analytical task of this call.

"We're not changing any of our metrics for the year, our guidance for the year on EBITDA."
— Natasha Fernandes, Chief Financial Officer

The arithmetic makes the tension concrete. First-half box office was $545M, being $260M in the first quarter and $285M in the second. A $1.4B full-year target therefore requires roughly $855M in the back half, which is 61% of the year and about 57% above the first-half run rate. The full-year figure would be a record against $1.28B in 2025.

Assessment: Three explanations fit. The benign one is calendar conservatism: no management raises a box-office number in July when the two largest titles have not finished playing, and IMAX has a history of guiding to numbers it beats. The second is that the Odyssey upside is being used to absorb weakness elsewhere, principally Greater China, which would make the reiteration an implicit downgrade of the rest of the slate. The third is that the back-half bar was always this steep and the guide always assumed it. We weight the first explanation most heavily and the second materially, and note that this is the question we would most want answered on the Q3 call.

2. Greater China Remains the Soft Spot, and Management Said So Plainly

Asked directly about China, the CEO did not soften it. The first half was disappointing, with the shortfall driven by film quality and slate timing rather than by any change in IMAX's position. Recent weeks have improved, two larger Chinese local-language titles moved out of Chinese New Year and are expected later in the year, and the market's 2027 slate looks materially stronger.

"So David, China's first half, as you know, was disappointing, their performance. In the last couple of weeks, it's actually started to pick up."
— Richard L. Gelfond, Chief Executive Officer

The forward evidence offered was specific rather than rhetorical: Spider-Man: Brand New Day presales in China are tracking consistent with Avatar 3, with IMAX holding over 50% of the market's presales for the title. The Odyssey was deliberately dated in China a month after the rest of the world, on the reasoning that global results bleed into local anticipation, which is the same sequencing that worked for Oppenheimer. Avengers: Doomsday is also set for China, where the prior Endgame delivered roughly a $45M IMAX opening weekend.

Assessment: The candour is worth more than a managed answer would have been, and the presale data points are checkable rather than atmospheric. But China has now been a drag for two consecutive quarters, it is where the 17 cancelled backlog locations sit, and it is the highest-margin geography in Content Solutions. The recovery case rests on titles that have not opened yet. This remains the most credible bear point in the story.

3. The Economics of IMAX 70mm Are Better Than Understood, and Deliberately Scarce

Pressed on whether the 70mm film footprint could be doubled given the demand, the CEO's answer was a detailed argument for why it should not be. The projector alone costs $50,000, the format requires an unusually large auditorium with the right aspect ratio, and the logistics of physical prints demand handling equipment most sites do not have. The economics only work where a film plays long enough to amortise all of it.

"So Eric, certainly, we could have more of them, and we're exploring ways to do that. But in a way, it's like a Rolls-Royce. The economics are very difficult to meet and only certain people can afford a Rolls-Royce."
— Richard L. Gelfond, Chief Executive Officer

The most valuable disclosure came at the end of the same answer: because IMAX subsidises the prints and participates in the print economics, it earns a significantly higher take rate in film theatres than in regular ones. Eleven new 70mm projector locations were brought online ahead of The Odyssey, taking the network to 41 worldwide.

Assessment: This reframes the 70mm network from a prestige asset into a margin asset, and it explains why a $6.3M weekend across 41 screens matters more to the P&L than the raw number suggests. The scarcity is not a constraint management is trying to solve; it is the source of the pricing power. Investors modelling 70mm expansion as the growth vector are modelling the wrong thing. The right frame is that each incremental 70mm site is high-return and the total addressable count is small, so the value accrues through utilisation and take rate rather than unit growth.

4. Pricing Is the Unexercised Lever, and It Is Not IMAX's to Pull

Asked whether the company would push for better economics from exhibitors given surging demand, the CEO declined on the revenue-share question and redirected to ticket price, where he was notably direct about the gap between what IMAX tickets fetch officially and what the market clears at.

"But one place I think there is room to make the model better is on price. And in fact, the exhibitors set the price. And frankly, with tickets at Lincoln Square being scalped for $1,000, I think there's room to move up the prices for film."
— Richard L. Gelfond, Chief Executive Officer

He was equally clear that IMAX would not renegotiate its share with partners, framing the current split as functional for all three parties and saying the company would not be greedy about it.

Assessment: A genuine, quantifiable, unexercised lever sitting outside the company's control. If exhibitors raise IMAX 70mm ticket prices toward what the secondary market demonstrates consumers will pay, IMAX participates through its share of the gate without spending a dollar. The refusal to touch the revenue split is the right long-run call and costs nothing today. We do not model any price benefit, and we note that a company declining to squeeze partners at the peak of its leverage is behaving like one that expects to need them for another sixty years.

5. Margin Expansion Was Delivered on a Weak Box-Office Quarter

The CFO made the point herself, and it is the most important framing of the print for anyone modelling the business.

"To put in context this quarter's strength, Q2 was not an exceptionally high box office quarter. However, our multiple drivers of revenue combined with operating leverage resulted in an adjusted EBITDA margin comfortably above our full year guidance of mid-40s margin and strong EPS growth of 65% year-over-year."
— Natasha Fernandes, Chief Financial Officer

Operating expenses including research and development but excluding stock compensation came in at $29M against $30M, with lower selling and administrative costs more than offsetting continued research investment.

Assessment: This is the quarter that decouples the earnings model from the box-office model in a demonstrable way, and it should change how the stock is analysed. A 46.6% margin on 1% box-office growth is a different business from the one that needed a blockbuster slate to hit 43%. The corollary is that the back-half margin should be well above the mid-40s guide given the box-office ramp, which reinforces the view that the full-year guidance is conservative.

6. The Merchandising Line Broke Out, and the Company Was Not Ready

An IMAX-branded popcorn bucket modelled on the 70mm camera used to shoot The Odyssey sold out in under two hours on the first drop, seven minutes on the second, and 63 seconds in China. More than 10,000 units moved through the company's own channels alone.

"I think for this year, we suffered a little because we didn't see how big it would be. But again, the goal this year was more to prove out the model. then to execute in a big way."
— Richard L. Gelfond, Chief Executive Officer

Management said an expanded merchandise programme is already being pulled forward for the remainder of the Odyssey run and that a more aggressive plan is in place for Dune: Part Three.

Assessment: Small in dollars, large as a signal. A brand that can clear inventory in 63 seconds has consumer equity that is not reflected anywhere in a model built on system sales and box-office share. The admission of under-production is the correct kind of candour and a solvable problem. We assign no revenue to this in our estimates and would treat any material contribution as upside.

7. The Portfolio Argument Against Single-Title Risk

In closing remarks, the CEO addressed the market's reaction to a title that had underperformed expectations earlier in the year, and used it to make a structural point about how the business should be read.

"If one movie doesn't do well, like I know a lot of our investors or analysts were in a craze because Grogu did X instead of X plus this. But we're pretty calm about it. We have a portfolio."
— Richard L. Gelfond, Chief Executive Officer

The 2026 back half runs to a dozen or more titles across categories: Spider-Man: Brand New Day in China, Japan and Korea, Resident Evil, Iñárritu's Digger with Tom Cruise, Godzilla Minus Zero as the first Filmed For IMAX title out of Japan, Ramayana Part 1 from India, an IMAX-exclusive theatrical release of a Netflix film directed by David Fincher, and Dune: Part Three at Christmas.

Assessment: The portfolio argument is correct in principle and stretched in this particular year. Geographic and genre breadth genuinely reduces single-title dependence over a multi-year horizon, and the 2027 slate described is deep. But the back half of 2026 requires 61% of the annual box-office target, and two titles shot with IMAX cameras are carrying a disproportionate share of it. The portfolio defends the franchise; it does not much defend this year's guide.

8. Sales Mix Shifted Toward System Sales, and the Company Says Not to Extrapolate

Eighteen of the 38 installations came under sales arrangements against 13 a year earlier, and backlog sales arrangements grew to 234 from 165. Asked whether this was a trend, management pushed back on its own good news.

"I think it's hard to predict in a quarter what the mix will be. And I think it's dangerous to assume 1 quarter is a trend."
— Richard L. Gelfond, Chief Executive Officer

Two structural reasons were nonetheless offered: IMAX has tightened return-on-investment criteria for joint revenue sharing in marginal territories, particularly China, and strong box office has led some partners to prefer owning the economics outright rather than sharing them. The CFO added that the prior year's joint revenue sharing installations had been front-loaded for tariff reasons, and that 31 such systems have been installed year to date, still more than the sales count.

Assessment: The mix shift is real, favourable, and partly a product of deliberate capital discipline in China. Sales arrangements convert to revenue and margin immediately rather than over a decade of gate-sharing, which is why the segment margin moved. The caution about extrapolation is fair, and we model the mix drifting back toward joint revenue sharing as the international new-build pipeline converts. The genuinely bullish read is the second reason offered: exhibitors choosing to buy rather than share is a revealed-preference statement about expected screen economics.

9. Capital Allocation Turned to Buybacks for the First Time in a Year

IMAX repurchased 404,866 shares at an average price of $33.91 for $13.7M during the quarter, against no repurchases in the prior-year quarter. Roughly $237M remains of a $500M authorisation. The balance sheet ended the quarter with $160M of cash against $292M of total debt, net leverage of 0.7 times, and $551M of available liquidity.

"And of course, as you've seen, Stephen, whenever we have excess cash flows or find the stock price is being underappreciated, we do then take that cash and invest right back into the business through share repurchases as well."
— Natasha Fernandes, Chief Financial Officer

First-half operating cash flow was $36M against $30M, and would have been roughly $10M higher but for lease incentives paid to exhibitors, most of which fell in the first quarter. Free cash flow after all capital expenditure including joint revenue sharing equipment was $23.0M against $8.1M.

Assessment: Buying stock at $33.91 in a quarter that ended with the shares at $47.29 is good timing, and the framing of repurchases as opportunistic rather than programmatic is the right posture for a company with a genuine growth-capital use for its cash. The lease-incentive spend is the more interesting allocation decision: it is cash out today converting into take-rate margin tomorrow, and the Technology Products and Services margin line suggests the trade is working. Free cash flow nearly tripling year over year on modest net income growth is a working-capital and capital-intensity story worth tracking.

10. The In-Vehicle Entertainment Partnership Is Optionality Acquired for Nothing

A newly announced partnership in China puts IMAX branding and technology into automotive entertainment systems. The commercial logic offered has two horizons: high-end Chinese manufacturers currently differentiate on audio-visual systems, and autonomous vehicles will eventually make in-car entertainment a purchase criterion.

"The best part of that is there's no R&D expense or capital expense for us. The way the deal is structured is most of that is absorbed by our partner. So we like not only the opportunity, but the structure of the deal."
— Richard L. Gelfond, Chief Executive Officer

Assessment: Correctly structured and correctly sized. A brand-licensing arrangement with no development or capital commitment is free optionality, and the honest description of it as speculative is preferable to the alternative framing. We ascribe zero value to it and would revisit only on disclosed unit economics.

Guidance & Outlook

Implied second-half ramp: First-half global box office of $545M against the $1.4B full-year target implies approximately $855M in the second half, or 61% of the year, requiring a run rate about 57% above the first half. On installations, 57 systems went in during the first half, so the 160 to 175 range requires 103 to 118 in the back half, a ratio consistent with the company's historical fourth-quarter weighting. On margin, first-half adjusted EBITDA margin was 42.6%; holding the full year to a mid-40s outcome requires roughly 46% or better in the second half, which the second quarter already delivered on materially lower box office.

Where the Street sits: The published sell-side target cluster tightened into the high $40s and $50 following the print, which the shares had substantially reached within four sessions. The debate on the Street is not about the quarter, which was unambiguous, but about whether the unchanged $1.4B box-office target is conservatism or a signal.

Guidance style: Conservative, and consistently so. The company set the $1.4B figure at the fourth-quarter 2025 print and has now reiterated it three times, through a first quarter that fell 13% and a second that grew 1%, without either lowering it when the first half disappointed or raising it when its largest catalyst outperformed. That symmetry is itself evidence the number is a floor management intends to clear rather than a forecast it is tracking.

Analyst Q&A Highlights

Which Odyssey Metrics Actually Demonstrate Durability

The opening line of questioning went straight to the distinction between a spectacular opening and a durable run, asking which indicators best evidenced continued momentum. The answer was structured around weekday holds rather than weekend totals, on the logic that a typical summer Monday runs about 10% of the preceding weekend and this one ran roughly 21%. Management also pointed to a newly opened site that had grossed about $800,000 in its first six months and then $400,000 in the film's first six days, framing it as evidence of first-time customers entering the network.

Q: "Odyssey, again, a big success, a lot of records for you, and you gave us a ton of sort of positive data points. What metrics do you think we should focus on that sort of best, I guess, in your view, demonstrate both the power of the film, the IMAX partnership and sort of give you the confidence that you can continue your momentum here over the coming weeks?"
— Michael Hickey, StoneX

A: "So a typical weekday in IMAX over the summer or theatrical is the Monday, it's about 10% of the weekend. And as you know, we did about $52 million over the weekend. So we were thinking maybe we'd do a little bit better, but the Monday number was around $11 million. By the way, we've had the same number on Tuesday and the same number on Wednesday."
— Richard L. Gelfond, Chief Executive Officer

Assessment: The weekday-hold framing is the right one and it is checkable in public daily data, which is why offering it is more credible than offering adjectives. A 21% Monday hold against a 10% norm is a statement about repeat and destination viewing rather than opening-weekend marketing. The new-site data point matters more for the network thesis than the title thesis: it suggests a blockbuster of this type functions as customer acquisition for screens that then retain a higher baseline.

Whether the 70mm Film Footprint Can Be Expanded

A direct challenge on capacity asked whether the film projection network could be doubled given evident demand, and whether that was financially or even manufacturably feasible. The response was an unusually complete cost breakdown and a clear no, grounded in the requirement that a film must play long enough to amortise print and logistics costs. The answer closed with the most commercially significant disclosure of the call, on take rates in film houses.

Q: "Rich, I know it's been many, many years since IMAX has manufactured a 70-millimeter film projection system. Given the response that you're seeing, not just for the Odyssey, but in recent times as well, is there any way to double the number of 70-millimeter film protection systems out there? Is it financially feasible? Is it from a manufacturing point, even feasible?"
— Eric Handler, ROTH Capital

A: "And by the way, we help subsidize the prints, and we participate in the economics around the print. So we get a significantly higher take rate in those film theaters than we get in regular theaters. So I think economically, that will end to our benefit, but it's finite."
— Richard L. Gelfond, Chief Executive Officer

Assessment: Management answered a growth question by defending a constraint, which is the correct answer and a rare one. The take-rate disclosure had not previously been quantified in this way and materially improves the read-through from the 41 film locations to third-quarter Content Solutions margin. The strategic implication is that the film network is a margin asset with a low unit ceiling, not a volume growth vector, and models treating 70mm site count as a driver are mis-specified.

Pushing for Better Terms From Exhibitors at Peak Leverage

A pointed question probed whether surging demand and rising per-screen averages create an opening to reprice new system agreements or revenue-share percentages in IMAX's favour. Management refused the premise on partner economics and redirected entirely to consumer ticket pricing, which sits with the exhibitor rather than with IMAX.

Q: "What about on the exhibitor side? And what have you seen in your kind of current discussions and kind of maybe what's in the recent backlog on new system installations to come in terms of your ability to kind of price those a little more advantageously for IMAX, either both on a sales side lease basis or in the revenue share percentages you get from the exhibitors?"
— Eric Wold, Texas Capital Securities

A: "So I think the current model working very well, Eric. And I think there's no reason to snatch defeat from the jaws of victory. So I think our pricing structure works pretty well. We get a good return. The studios get a good return. The exhibitors get a good return. We're not going to be pigs about it."
— Richard L. Gelfond, Chief Executive Officer

Assessment: A clear answer to a question many managements would have hedged, and a defensible one. Repricing partners at the moment of maximum leverage buys one cycle of margin and costs a decade of goodwill in a business with roughly 1,800 exhibitor relationships and a sixty-year history. The redirect to ticket price is the more valuable insight, because that lever is genuinely unexercised and IMAX participates in it without conceding anything.

Greater China Trajectory and the Second-Half Recovery Case

The most substantive challenge of the call asked management to separate whether Chinese weakness reflects film quality or consumer conditions, and to frame the near-term outlook. The answer conceded the first half without qualification, then offered specific and verifiable forward markers rather than reassurance, including presale share data on a coming title and the reasoning behind a deliberate release-date decision.

Q: "Rich, it would be great if you could update on China and just the moviegoing trends in the first half and more recently, how do you see performance as being impacted by film quality or consumer trends and just kind of your near-term outlook on the Odyssey and Spider-Man."
— David Karnovsky, JPMorgan

A: "The presales for Spider-Man in China have been pretty good. They've been consistent with kind of what Avatar 3's presales were. I think we're over 50% of the presales in China for that movie. So we're cautiously optimistic about that. I think it was a smart move in China by opening Odyssey a month later than it opened in the rest of the world because I think the rest of the world's results will bleed over and will give the movie momentum going in."
— Richard L. Gelfond, Chief Executive Officer

Assessment: The candour is genuine and the data are specific, which is the best that can be offered on a market whose recovery depends on unreleased titles. The staggered Odyssey release into China is a real strategic choice rather than a scheduling accident, and it borrows a playbook that worked before. The residual concern is unchanged: every element of the China recovery case is forward-looking, and China is simultaneously where backlog was cancelled and where Content Solutions margin is being lost.

The Systems Mix Shift and Whether It Signals a Trend

A question on network evolution noted the unusually high proportion of outright system sales in the quarter and the lower investment in joint revenue sharing equipment, asking whether this indicated a pull-forward, an acceleration toward the high end of installation guidance, or a change in capital priorities alongside the resumption of buybacks. Management resisted the trend reading while supplying two structural reasons that partly support it, and the CFO added a prior-year comparability point.

Q: "And thinking about your network evolution, it seems like you did have greater system sales than is typical here in the second quarter. Is there any pull forward? Or is there an acceleration? Or is this an indication that you'll be closer to the high end of your install guidance for the year?"
— David Joyce, Seaport Research Partners

A: "The other part that to be considered there is last year, and we talked about this last year, we front-loaded the JVs because of certain tariffs and taxes, and we wanted to make sure that we ship them ahead of time. But even as you look at this year, David, we've installed 31 JV systems year-to-date. So it is more than the sales systems."
— Natasha Fernandes, Chief Financial Officer

Assessment: Management declined to claim credit for a favourable mix it partly engineered, which is the conservative and correct posture, though the reasons given (tighter return criteria in marginal territories, partners preferring to own the economics) do describe something more durable than quarterly noise. The 31 joint revenue sharing installations year to date is the right rebuttal to a pure de-emphasis reading. The exchange left the installation guidance question unanswered, which given first-half installations of 57 against a 160 to 175 full-year range is a live modelling issue.

Free Cash Flow Conversion and Capital Return Priorities

A follow-on question sought an updated view on the conversion of adjusted EBITDA into free cash flow for the year and on the broader capital allocation framework. The response reaffirmed guidance, then made the priority ordering explicit: network investment first, with repurchases as the residual use when cash is surplus or the share price is judged to be undervaluing the business.

Q: "Natasha, curious if you could just update us on your latest thinking around EBITDA to free cash flow conversion for the year, if any of that outlook is changing or is remaining similar? And then perhaps related to that, just as you look ahead, it would be great to get your updated sense for how you're thinking about capital allocation and capital returns more broadly."
— Stephen Laszczyk, Goldman Sachs

A: "Our cash from ops of $36 million actually would have been $10 million higher, but we've decided to invest through those lease incentives as well. So we are highly invested in growing our network and continuing to as we grow the network, then realize that incrementality through our model and create growth each year for our financial metrics."
— Natasha Fernandes, Chief Financial Officer

Assessment: The answer was directionally clear and numerically thin, offering no conversion ratio despite being asked for one twice. What it did establish is that the lease-incentive spend is a deliberate margin investment rather than a working-capital leak, and the Technology Products and Services take-rate commentary corroborates that. Investors should read reported operating cash flow with the incentive spend added back when assessing underlying conversion, which puts first-half cash generation at roughly $46M on a comparable basis.

Slate Congestion and Whether Studios Are Dating Films Badly

A question on release-calendar optimisation asked whether studios are leaving box office on the table through clustering, and how much opportunity exists to spread the calendar. Management engaged the macro argument candidly, naming two specific instances in the current slate where competing tentpoles landed on top of IMAX-centric titles, and endorsed the questioner's premise.

Q: "I'm just curious on how you feel these studios are utilizing just the overall calendar and like how much more opportunity there is to kind of expand that release calendar to better optimized box office, but specifically IMAX's box office?"
— Patrick Sholl, Barrington Research

A: "I mean, did Spider-Man have to date on the third week of Odyssey or was there a better date? Could Avengers have dated differently than right on top of Dune? I think historical trends and what are good weeks and what are bad weeks kind of too much in the zeitgeist of the entire entertainment network."
— Richard L. Gelfond, Chief Executive Officer

Assessment: This is the most consequential answer on the call for second-half modelling, and it was volunteered rather than extracted. Two of the largest remaining titles are dated on top of the two IMAX-camera films that the full-year guide depends on, which forces screen-allocation choices between them. It is also the clearest available explanation for why guidance was reiterated rather than raised: Odyssey outperformance does not fully convert when the network cannot hold it and a competing tentpole is claiming screens. The constraint is capacity allocation, not demand.

What They're NOT Saying

1. No explanation for reiterating rather than raising the box-office target. The CEO said he was near-certain The Odyssey would beat its budget, and the full-year figure did not move. No analyst asked why, and no explanation was volunteered. This is the single largest unaddressed question from the call.
2. No Odyssey ultimate. Management said it had modelled an aggressive ultimate for the film and expected to beat it, then declined to state the figure. The ~$100M first-week disclosure is a running total, not a forecast.
3. No quantified free cash flow conversion for the year, despite being asked directly and then again as a follow-up. The answer described priorities rather than a ratio.
4. No installation-cadence guidance for the second half. With 57 systems installed against a 160 to 175 full-year range, 103 to 118 must land in two quarters. Asked whether the year would come in at the high end, management declined to say.
5. No update on Project Hail Mary's final IMAX box office. The prior quarter's flagship streamer-format proof point, last disclosed above $90M, was not mentioned. Its final figure is a direct test of the streamer economics that were central to last quarter's bull case.
6. No detail on the 17 cancelled Greater China backlog locations beyond the filing's statement that they were mutually deemed no longer beneficial. No commentary on whether further rationalisation is expected, and no analyst raised it.
7. No commentary on Content Solutions margin compression. Segment margin fell from 66% to 63% and missed consensus gross margin by $1.3M. The decline was not addressed in prepared remarks or in Q&A.
8. No merchandising revenue figure or margin structure. Unit anecdotes were offered (10,000 buckets, sell-out times) with no dollar contribution, no gross margin, and no 2027 plan sizing.
9. No sizing of the in-vehicle entertainment opportunity. The deal structure was described as capital-free for IMAX; the addressable market question posed alongside it went unanswered.
10. No 2027 guidance framework, though the 2027 slate was described in unusual detail, including at least four IMAX 70mm titles. Given the through-2028 margin framework from the December investor day, an update on progress toward the 50%-plus margin target was notably absent.

Market Reaction

• Pre-print setup: IMAX closed at $39.30 on July 22, the session before the before-the-open release. The stock entered the print up 6.3% year to date but down 12.6% over the prior 30 days from a 52-week closing high of $44.97 set in late June, and up 35.4% over twelve months. The S&P 500 was up 9.5% year to date over the same span. The setup was therefore a drawdown into the print, not a run into it, even though The Odyssey had already opened strongly the week before.
• Reaction session: Shares opened at $41.75, a 6.2% gap, traded as high as $45.16, and closed at $43.96 for a gain of 11.9% or $4.66. Volume was 6.4M shares against a 30-day average of 1.0M, a multiple of 6.2 times. The S&P 500 fell 1.2% on the same session, making the relative move roughly 13 points.
• Follow-through: The stock gave back 1.3% to $43.38 on July 24, then advanced 4.0% to $45.11 on July 27 and 4.8% to $47.29 on July 28, both new 52-week closing highs, on ordinary volume of roughly 1.4M shares. Cumulative move from the pre-print close is 20.3%.
• Sell-side response: Price targets moved up broadly into a cluster in the high $40s to $50, with the bulk of published upside reached within four sessions. One firm raised its target while retaining a neutral rating, citing execution risk against the full-year box-office target.

The shape of this reaction is more informative than its size. A 6.2% opening gap that extends to 11.9% by the close means buying persisted through the session rather than fading, and the absence of a give-back over the following three sessions, on volume that normalised immediately, argues the move was repositioning rather than a squeeze. The stock going on to make new 52-week highs four and five sessions after the print, on a quarter of the reaction-day volume, is the signature of investors building positions rather than trading a headline.

What the market appears to have priced is not the quarter but the resolution of a binary. Since the December investor day, the bull case has rested on the proposition that a purpose-built IMAX title can command a step-change share of a film's gross. Until July that was a forecast, and the stock had de-rated 12.6% in the month before the print despite The Odyssey having already opened. The 20% global share on under 1% of screens converted the forecast into an observation, and the re-rating followed. That also explains why the reaction so far exceeds what a 9% revenue beat would normally justify: the P&L beat was the occasion for the move, not its cause.

The corollary is uncomfortable for new money at $47.29. The binary that has now resolved cannot resolve twice, and the published sell-side upside has largely been captured. From here the stock needs estimate revisions, and estimate revisions need the second half to deliver the $855M of box office the reiterated guide implies.

Street Perspective

Debate: Is the Unchanged $1.4B Box-Office Target Conservatism or a Warning?

Bull view: The company set $1.4B at the fourth-quarter print and has reiterated it through a first quarter down 13% and a second up 1% without cutting, which means the number was never dependent on first-half strength. No management raises a full-year box-office figure in July with its two largest titles still in front of it, and this one has a documented habit of guiding to numbers it beats. The CEO's statement that The Odyssey will beat its internal budget is the tell; the guide is a floor.

Bear view: A company whose single largest catalyst is running ahead of plan and which leaves the full-year number untouched is telling you something else is running behind. The candidates are visible in the print: Greater China was called disappointing, 17 China backlog locations were cancelled, and Content Solutions gross margin has now compressed year over year for two consecutive quarters. The reiteration is arithmetically an implied downgrade of everything that is not The Odyssey.

Our take: The bull view is more likely and the bear view is not wrong. Management's own answer on slate congestion supplies the missing mechanism, and it favours neither camp cleanly: two of the largest remaining titles are dated directly against the two IMAX-camera films the guide depends on, so incremental Odyssey demand cannot fully convert when the network has to allocate screens. That is a capacity constraint rather than a demand problem, and it caps upside without implying weakness. We model the full year modestly above $1.4B and treat the reiteration as roughly 70% conservatism and 30% offset of China softness.

Debate: Has the Business Genuinely Decoupled From Box-Office Beta?

Bull view: This quarter is the proof. Box office grew 1% and adjusted EBITDA grew 23% with margin up 400 basis points, in a period the CFO explicitly described as not an exceptionally high box-office quarter. System sales, renewals, the lease-incentive take-rate trade and rising system average selling prices now generate enough independent margin that the earnings line no longer requires a blockbuster slate to expand. The revenue mix has shifted toward up-front, high-margin, box-office-independent lines, and that shift is durable.

Bear view: One quarter is not a decoupling. The systems strength reflects installation timing, a favourable sales-versus-joint-revenue-sharing mix that management itself warned against extrapolating, and a prior-year comparison distorted by front-loaded shipments. Meanwhile the segment that actually embodies the premium thesis, Content Solutions, missed consensus and compressed margin for a second straight quarter. Strip out the mix and the underlying content economics got worse, not better.

Our take: The decoupling is real but narrower than the bulls claim. Two of the three drivers, the lease-incentive take rate and system pricing rising with box-office projections, are structural and were explicitly described as continuing. The third, incrementality above $250M of quarterly box office, is not a decoupling at all; it is box-office leverage wearing a different label, and it reverses below the threshold. The honest formulation is that IMAX has raised its floor without severing the link to the gate. That is worth a higher multiple than a pure exhibition-beta business, which is roughly what the market has just granted it.

Debate: Does The Odyssey Change the Long-Run Model or Just This Year's Numbers?

Bull view: It changes the model. A 20% share of a global opening on under 1% of screens establishes a new ceiling that studios and filmmakers can now see, and the disclosed take-rate premium in film houses means that ceiling converts to IMAX revenue at above-average rates. At least four IMAX 70mm titles are already set for 2027, an IMAX-exclusive theatrical window has been secured with a streamer, and Filmed For IMAX is extending into animation, Japanese and Indian production. The format has become the thing prestige filmmakers compete to use, which is a supply-side moat no exhibitor can replicate with a bigger screen.

Bear view: It changes this year's numbers. One director with an unrepeatable relationship to the format shot one film with equipment built specifically for him over several years, and the result is being extrapolated into a business model. The film network is capped at roughly 41 locations by economics management itself described in detail, ticket pricing sits with exhibitors rather than IMAX, and the 2027 slate depends on the same handful of directors. Meanwhile the routine slate is what pays the bills, and the routine slate produced 1% box-office growth this quarter.

Our take: The bulls have the better of this, with one important qualification. The durable change is not the film itself but what it demonstrated to the supply side, and supply-side demonstrations compound in a way that single hits do not. The qualification is the one the bears identify correctly: the 70mm network is deliberately finite, so the model scales through take rate, utilisation and system pricing rather than through film-location count. Investors expecting the next four quarters to look like the Odyssey opening will be disappointed; investors underwriting a structurally higher ceiling on what the format can earn per title, and a widening queue of filmmakers wanting to use it, are underwriting the right thing.

Model Update

Valuation. At the July 28 close of $47.29 on 56.6M diluted shares, equity value is approximately $2.68B. Adding $292M of total debt and deducting $160M of cash gives an enterprise value of roughly $2.81B. Against trailing twelve-month total adjusted EBITDA of $187.4M that is about 15.0 times, or 16.2 times on the $173.5M attributable-to-common basis. Against our revised FY26 estimate of $215M it is roughly 13.1 times, and against a FY27 estimate of $255M roughly 11.0 times. On earnings, the stock trades at about 25 times our FY26 adjusted EPS midpoint of $1.88.

Fair value range raised to $48-$58 from $40-$52. The range corresponds to roughly 11 to 13.5 times our FY27 adjusted EBITDA estimate of $255M, a band we consider defensible for a business compounding EBITDA in the mid-to-high teens with a demonstrated premium tier, a net leverage ratio of 0.7 times and an active repurchase authorisation. The midpoint of $53 implies roughly 12% upside from the current price over a twelve-month horizon. That is a narrower margin of safety than we underwrote at $33 in May, and the range would need to move again on evidence rather than enthusiasm.

Thesis Scorecard Post-Earnings

Overall: Thesis strengthened on substance, weakened on price. The central bull pillar was confirmed more emphatically than a single quarter usually allows, and the operating-leverage pillar moved from promised to demonstrated. Against that, two bear points escalated and one new one is worth formally tracking: the box-office concentration in the back half, the re-rating of the stock, and the quiet two-quarter compression in Content Solutions margin that nobody on the call asked about.

Action: Hold existing positions and add only on weakness toward the low $40s. New money at $47.29 is underwriting roughly 12% upside to our revised midpoint with the year's largest execution test still ahead, which is a materially different proposition from the one available in May.

Rating & Action

Maintaining Outperform. Fair value range raised to $48-$58 from $40-$52. The quarter beat consensus by 9% on revenue and 54% on adjusted EPS, expanded adjusted EBITDA margin by 400 basis points to 46.6% on box office that grew 1%, and was followed by the largest like-for-like IMAX global opening in company history. The proposition that has underpinned this coverage since initiation, that IMAX 70mm and Filmed For IMAX constitute a premium tier the rest of exhibition cannot copy, moved from thesis to observation this month.

We are maintaining rather than upgrading for two reasons. The first is price: the stock has advanced 20.3% from the pre-print close and roughly 43% since we last wrote, and now trades at approximately 13 times our FY26 adjusted EBITDA estimate against a published sell-side target cluster it has already reached. The second is that the quarter's beat came from the systems business while the content business missed, and the year's guidance was reiterated rather than raised at precisely the moment its largest catalyst outperformed. Neither is disqualifying. Both argue for owning the position rather than adding to it here.

What would change our view:

• Upgrade conviction: Q3 adjusted EBITDA margin above 50% with Content Solutions segment margin recovering above 66%; second-half box office tracking above $900M on the monthly disclosures; Odyssey lifetime IMAX gross above $250M once China, Japan and Korea have played; a raised or exceeded full-year box-office figure at the Q3 print; backlog stabilising above 420 with continued sales-arrangement mix shift; disclosed merchandising economics of any material size.
• Downgrade to Hold: Q3 adjusted EBITDA margin below 46% despite the Odyssey run; Content Solutions margin compressing for a third consecutive quarter; second-half box office tracking below $800M by the October monthly update; further Greater China backlog cancellations; the shares above roughly $58 without accompanying estimate revisions.

Key watch items into Q3 2026 (October):

• The Odyssey's performance in South Korea (opens August 5), Mainland China (August 14) and Japan (September 11), and its lifetime IMAX gross against Oppenheimer's $190M
• Whether Content Solutions segment margin recovers above 66% on the Odyssey mix, and whether it holds there
• Second-half box-office pace against the roughly $855M the reiterated guide implies, tracked through the company's monthly investor-relations disclosures
• Whether the full-year box-office figure is raised at the Q3 print, which would resolve the conservatism-versus-offset question
• Installation cadence: 103 to 118 systems must land in the back half against 57 in the first
• Backlog direction after two quarters of decline, and any further Greater China rationalisation
• Spider-Man: Brand New Day performance in China against the Avatar 3 presale comparison
• Any disclosure sizing the merchandising line, which currently carries no value in our estimates